^
Association details:
Biomarker:NRG3 deletion
Cancer:Colorectal Cancer
Regimen:FOLFOX (leucovorin calcium + oxaliplatin + 5-fluorouracil)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

Deletions in metastatic colorectal cancer with chromothripsis

Published date:
12/10/2019
Excerpt:
Four patients (40%) with PFS over 14 months, presented with NRG3 deletion (oncogene) what could possibly decrease proliferation of cancer cells via decreasing epidermal growth factor receptor (EGFR) activation. Longer PFS was associated with deletion of MIR1269, MIR4465, MIR1261 and MIR4490.
DOI:
10.32471/exp-oncology.2312-8852.vol-41-no-4.13841